Nayab Singh Saini has ordered the rollout of a real-time medicine tracking system in Haryana hospitals, aiming to curb outside prescriptions and improve patient care.
Marksans Pharma gets USFDA nod for benzonatate capsules, marking a key step in its push into the US generics market.
Takeda Pharmaceutical Company is a step closer to dengue vaccine Import approval in India after receiving a positive recommendation from the Subject Expert Committee, marking a major development in the country’s fight against mosquito-borne diseases.
VLCC has taken a major step by introducing Global Laser Certification access in India through a new partnership with the National Council on Laser Certification (NCLC), USA. With this move, VLCC becomes the exclusive proctor for NCLC exams...
Indian pharmaceutical firms looking to benefit from the global biologics boom are facing major obstacles, as China's hold on biotech supply chains becomes even stronger.
Sanofi has secured a conditional marketing authorization for Rezurock (belumosudil) in the EU, marking a major step forward in chronic GVHD treatment.
Rusan Healthcare has announced the launch of the APOSAN 3ml Pen, a multi-dose delivery pen device designed for better treatment in Parkinson’s disease ON-OFF episodes.
Granules India Limited has announced that its wholly owned subsidiary, Granules Life Sciences (GLS), has received a Voluntary Action Indicated (VAI) classification from the US Food and Drug Administration (USFDA) following an inspectio...
Fortis Hiranandani Hospital, Navi Mumbai, successfully hosted a train-the-trainer live surgical workshop on 28th March 2026, focusing on advanced gynecological endoscopy training amongst young practitioners.
Wockhardt has moved closer to market approval after its antibiotic Zaynich received a positive nod from the Central Drugs Standard Control Organization, marking a breakthrough in antibiotic space.